Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab maintenance after autologous transplant in first-line mantle cell lymphoma
2007-004644-70Phase 3Completed
- Sponsor
- Goelams
- Start
- Jun 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in mantle cell lymphoma (MCL) comparing Rituximab maintenance with Observation / surveillance (2 arms). Primary endpoint: 4-year event-free survival. Started Jun 2010; status: completed.
02
Drugs
rituximab
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on 2007-004644-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004644-70.